# mbiomics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/mbiomics

- Industry: Biotechnology
- Headquarters: Germany
- Website: www.mbiomics.com
- Total disclosed funding: $41M
- Latest round: Series A (Oct 16, 2026)
- Investors on record: 9

## About

Founded in 2020 and based in Munich, Germany, Mbiomics GmbH operates as a biotechnology company that focuses on researching therapeutic approaches using the microbiome. Laura Figulla (CEO), Markus Rinecker (CMO/CFO), Johannes B. Woehrstein (CTO), and Heinrich Grabmayr are the co-founders of the company. In March 2023, Mbiomics GmbH raised EUR 13 million in Series A funding from MIG Verwaltungs AG, including Bayern Kapital and High-Tech Gründerfonds. In April 2026, mbiomics GmbH raised EUR 12 million in series A funding from MIG Capital and Bayern Kapital.

The company offers a variety of products, such as Mbiomics Gold, the gold standard for microbiome analysis, which allows for comparable gut microbiome profiling; Mbiomics Monitor, which enables users to monitor microbiome modulation with sampling frequency; and the Mbiomics Stratos Platform, which enables microbiome profiling by combining biomarker panels and turnaround times. The firm’s partners include the University of Zurich and TUM.

The company will use the April 2026 funding to expand investigational new drug–enabling data and speed up good manufacturing practice development and manufacturing ahead of clinical evaluation.

## Funding rounds

- Series A, Oct 16, 2026, $13M
- Series A, Apr 15, 2026, $14M — MIG Capital, Bayern Kapital, ATHOS Biopharma GmbH
- Series A, Mar 20, 2023, $14M — High-Tech Gruenderfonds, MIG Capital, Bayern Kapital, Winning Mindset Ventures, thehighground GmbH, Ricon, ATHOS Biopharma GmbH, CORUS Life Sciences GmbH & Co. KG, SCM Seven Capital Management GmbH

## Investors

- High-Tech Gruenderfonds (https://capitalatlas.ai/funds/high-tech-gruenderfonds) — Series A
- MIG Capital (https://capitalatlas.ai/funds/mig-capital) — Series A
- Bayern Kapital (https://capitalatlas.ai/funds/bayern-kapital) — Series A
- Winning Mindset Ventures — Series A
- thehighground GmbH — Series A
- Ricon (https://capitalatlas.ai/funds/ricon) — Series A
- ATHOS Biopharma GmbH — Series A
- CORUS Life Sciences GmbH & Co. KG — Series A
- SCM Seven Capital Management GmbH — Series A